Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $135000.0.

  • Jaguar Health's Share-based Compensation fell 5645.16% to $135000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 4154.51%. This contributed to the annual value of $1.6 million for FY2024, which is 2230.11% down from last year.
  • As of Q3 2025, Jaguar Health's Share-based Compensation stood at $135000.0, which was down 5645.16% from $279000.0 recorded in Q2 2025.
  • Jaguar Health's 5-year Share-based Compensation high stood at $1.2 million for Q3 2021, and its period low was $135000.0 during Q3 2025.
  • Its 5-year average for Share-based Compensation is $618842.1, with a median of $537000.0 in 2023.
  • As far as peak fluctuations go, Jaguar Health's Share-based Compensation soared by 7843.75% in 2021, and later crashed by 6523.64% in 2022.
  • Over the past 5 years, Jaguar Health's Share-based Compensation (Quarter) stood at $1.1 million in 2021, then crashed by 65.24% to $397000.0 in 2022, then surged by 45.34% to $577000.0 in 2023, then tumbled by 36.4% to $367000.0 in 2024, then plummeted by 63.22% to $135000.0 in 2025.
  • Its Share-based Compensation stands at $135000.0 for Q3 2025, versus $279000.0 for Q2 2025 and $301000.0 for Q1 2025.